Do diagnostic delays in cancer matter?
- PMID: 19956171
- PMCID: PMC2790696
- DOI: 10.1038/sj.bjc.6605384
Do diagnostic delays in cancer matter?
Abstract
Background: The United Kingdom has poorer cancer outcomes than many other countries due partly to delays in diagnosing symptomatic cancer, leading to more advanced stage at diagnosis. Delays can occur at the level of patients, primary care, systems and secondary care. There is considerable potential for interventions to minimise delays and lead to earlier-stage diagnosis.
Methods: Scoping review of the published studies, with a focus on methodological issues.
Results: Trial data in this area are lacking and observational studies often show no association or negative ones. This review offers methodological explanations for these counter-intuitive findings.
Conclusion: While diagnostic delays do matter, their importance is uncertain and must be determined through more sophisticated methods.
References
-
- Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF (2006) The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol 142: 1422–1427 - PubMed
-
- Bankhead CR, Kehoe ST, Austoker J (2005) Symptoms associated with diagnosis of ovarian cancer: a systematic review. Br J Obstet Gynaecol 112: 857–865 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
